Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect von Chen, D.M., Odueyungbo, A., Csinady, E., Gearhart, L., Lehane, P., Cheu, M., Maho‐Vaillant, M., Prost‐Squarcioni, C., Hebert, V., Houivet, E., Calbo, S., Caillot, F., Golinski, M.L., Labeille, B., Picard‐Dahan, C., Paul, C., Richard, M.A., Bouaziz, J.D., Duvert‐Lehembre, S., Bernard, P., Caux, F., Alexandre, M., Ingen‐Housz‐Oro, S., Vabres, P., Delaporte, E., Quereux, G., Dupuy, A., Debarbieux, S., Avenel‐Audran, M., D'Incan, M., Bedane, C., Bénéton, N., Jullien, D., Dupin, N., Misery, L., Machet, L., Beylot‐Barry, M., Dereure, O., Sassolas, B., Benichou, J., Musette, P., Joly, P.

Volltext

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis von Lehane, P B, Lacey, S, Hessey, E W, Jahreis, A

Volltext

FRI0216 Effect of concomitant statins on rituximab efficacy in patients with ra von Vashishtha, A., Lehane, P. B., Hessey, E. W.

Volltext

Sustained benefit in rheumatoid arthritis following one course of rituximab : improvements in physical function over 2 years von STRAND, V, BALBIR-GURMAN, A, PAVELKA, K, EMERY, P, LI, N, YIN, M, LEHANE, P. B, AGARWAL, S

Volltext

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris von Werth, Victoria P, Joly, Pascal, Mimouni, Daniel, Maverakis, Emanual, Caux, Frédéric, Lehane, Patricia, Gearhart, Liudmila, Kapre, Audrey, Pordeli, Pooneh, Chen, Diana M

Volltext

SAT0131 Long-Term Safety of Rituximab: Pooled Analysis of the Rheumatoid Arthritis Global Clinical Trial Programme Over 11 Years von van Vollenhoven, R. F., Emery, P., Bingham, C. O., Keystone, E., Fleischmann, R. M., Furst, D., Hessey, E. W., Vashishtha, A., Mehbob, A., Lehane, P. B.

Volltext

Improving the cleaning procedure to make kitchen floors less slippery von Quirion, F., Poirier, P., Lehane, P.

Volltext

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients von van Vollenhoven, Ronald F, Emery, Paul, Bingham, Clifton O, Keystone, Edward C, Fleischmann, Roy M, Furst, Daniel E, Tyson, Nicola, Collinson, Neil, Lehane, Patricia B

Volltext

MAST and the impact of low aspect ratio on tokamak physics von Lloyd, B, Ahn, J-W, Akers, R J, Appel, L C, Applegate, D, Axon, K B, Baranov, Y, Brickley, C, Bunting, C, Buttery, R J, Carolan, P G, Challis, C, Ciric, D, Conway, N J, Cox, M, Counsell, G F, Cunningham, G, Darke, A, Dnestrovskij, A, Dowling, J, Dudson, B, Dunstan, M R, Field, A R, Gee, S, Gryaznevich, M P, Helander, P, Hender, T C, Hole, M, Joiner, N, Keeling, D, Kirk, A, Lehane, I P, Lott, F, Maddison, G P, Manhood, S J, Martin, R, McArdle, G J, McClements, K G, Meyer, H, Morris, A W, Nelson, M, O'Brien, M R, Patel, A, Pinfold, T, Preinhaelter, J, Price, M N, Roach, C M, Rozhansky, V, Saarelma, S, Saveliev, A, Scannell, R, Sharapov, S, Shevchenko, V, Shibaev, S, Stammers, K, Storrs, J, Sykes, A, Tabasso, A, Taylor, D, Tournianski, M R, Turner, A, Turri, G, Valovic, M, Volpe, F, Voss, G, Walsh, M J, Watkins, J R, Wilson, H R, Wisse, M

Volltext

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect von Chen, D M, Odueyungbo, A, Csinady, E, Gearhart, L, Lehane, P, Cheu, M, Maho‐vaillant, M, Prost‐squarcioni, C, Hebert, V, Houivet, E, Calbo, S, Caillot, F, Golinski, M L, Labeille, B, Picard‐dahan, C, Paul, C, Richard, M A, Bouaziz, J D, Duvert‐lehembre, S, Bernard, P, Caux, F, Alexandre, M, Ingen‐housz‐oro, S, Vabres, P, Delaporte, E, Quereux, G, Dupuy, A, Debarbieux, S, Avenel‐audran, M, d'Incan, M, Bedane, C, Bénéton, N, Jullien, D, Dupin, N, Misery, L, Machet, L, Beylot‐barry, M, Dereure, O, Sassolas, B, Benichou, J, Musette, P, Joly, P

Volltext

H-mode plasmas in the MAST spherical tokamak von Field, A R, Carolan, P G, Akers, R J, Arends, E R, Axon, K, Buttery, R J, Conway, N J, Counsell, G F, Cunningham, G, Fielding, S J, Gryaznevich, M, Kirk, A, Lehane, I P, Lloyd, B, McGrath, M A, Meyer, H, Ribeiro, C, Sykes, A, Tabasso, A, Tournianski, M R, Valovic, M, Walsh, M J, Wilson, H R, MAST, the, Teams, NBI

Volltext

Étude de phase III, randomisée, en double insu évaluant l’efficacité et la tolérance du rituximab par rapport au mycophénolate mofétil dans le pemphigus vulgaire von Joly, P., Werth, V., Mimouni, D., Maverakis, E., Caux, F., Lehane, P., Gearhart, L., Pordeli, P., Chen, D.

Volltext

Improving the cleaning procedure to make kitchen floors less slippery: Slips, Trips and Falls von QUIRION, F, POIRIER, P, LEHANE, P

Volltext

Overview of recent experimental results on MAST von Lloyd, B, Ahn, J-W, Akers, R.J, Appel, L.C, Arends, E.R, Axon, K.B, Buttery, R.J, Byrom, C, Carolan, P.G, Challis, C, Ciric, D, Conway, N.J, Cox, M, Counsell, G.F, Cunningham, G, Darke, A, Dnestrovskij, A, Dowling, J, Dunstan, M.R, Field, A.R, Fielding, S.J, Gee, S, Gryaznevich, M.P, Helander, P, Hole, M, Hood, M.B, Jones, P.A, Kirk, A, Lehane, I.P, Maddison, G.P, Manhood, S.J, Martin, R, McArdle, G.J, McClements, K.G, McGrath, M.A, Meyer, H, Morris, A.W, Nielsen, S.K, Nightingale, M, Patel, A, Pinfold, T, Price, M.N, Qin, J, Ribeiro, C, Roach, C.M, Robinson, D.C, Sauter, O, Shevchenko, V, Shibaev, S, Stammers, K, Sykes, A, Tabasso, A, Taylor, D, Tournianski, M.R, Turri, G, Valovic, M, Voss, G, Walsh, M.J, Warder, S, Watkins, J.R, Wilson, H.R, Yang, Y, You, S, teams, the MAST and NBI

Volltext

FRI0203 Infection risk in patients with low immunoglobulins following rituximab treatment in rheumatoid arthritis von van Vollenhoven, R., Silverman, G.J., Bingham, C.O., Durez, P., Lehane, P.B., Tyson, N., Fisheleva, E.

Volltext

Overview of MAST results von Counsell, G.F, Akers, R.J, Appel, L.C, Applegate, D, Axon, K.B, Baranov, Y, Brickley, C, Bunting, C, Buttery, R.J, Carolan, P.G, Challis, C, Ciric, D, Conway, N.J, Cox, M, Cunningham, G, Darke, A, Dnestrovskij, A, Dowling, J, Dudson, B, Dunstan, M.R, Delchambre, E, Field, A.R, Foster, A, Gee, S, Gryaznevich, M.P, Helander, P, Hender, T.C, Hole, M, Howell, D.H, Joiner, N, Keeling, D, Kirk, A, Lehane, I.P, Lisgo, S, Lloyd, B, Lott, F, Maddison, G.P, Manhood, S.J, Martin, R, McArdle, G.J, McClements, K.G, Meyer, H, Morris, A.W, Nelson, M, O'Brien, M.R, Patel, A, Pinfold, T, Preinhaelter, J, Price, M.N, Roach, C.M, Rozhansky, V, Saarelma, S, Saveliev, A, Scannell, R, Sharapov, S, Shevchenko, V, Shibaev, S, Stammers, K, Storrs, J, Sykes, A, Tabasso, A, Tallents, S, Taylor, D, Tournianski, M.R, Turner, A, Turri, G, Valovic, M, Volpe, F, Voss, G, Walsh, M.J, Watkins, J.R, Wilson, H.R, Wisse, M

Volltext

AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to... von Keystone, E., Cohen, S.B., Emery, P., Kremer, J.M., Dougados, M., Loveless, J.E., Chung, C., Wong, P., Lehane, P.B., Tyrrell, H.

Volltext

FRI0201 Analysis of infection risk in patients with limited return of peripheral B cells after a period of 2 years or more following any rituximab treatment course in RA clinical t... von Mease, P., van Vollenhoven, R., Durez, P., Sheeran, T., Dougados, M., Gόmez-Reino, J.J., Tyson, N., Mehbob, A., Lehane, P.B.

Volltext

FRI0183 Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment... von Keystone, E., Cohen, S.B., Emery, P., Kremer, J.M., Dougados, M., Loveless, J.E., Chung, C., Wong, P., Lehane, P.B., Tyrrell, H.

Volltext

THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme von van Vollenhoven, R.F., Emery, P., Bingham, C.O., Keystone, E., Fleischmann, R., Furst, D.E., Tyson, N., Mehbob, A., Lehane, P.B.

Volltext